Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Sabbagh

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Dementia and Geriatric Cognitive Disorders|September 14, 2007
Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's diseaseM N Sabbagh, T Lahti, D J Connor, et al.
Neurology|February 18, 2011
Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotesR J Caselli, A C Dueck, D E C Locke, et al.
Molecular Psychiatry|March 12, 2014
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter studyP M Doraiswamy, R A Sperling, K Johnson, et al.
European Journal of Neurology|August 24, 2017
GBA mutations in Parkinson disease: earlier death but similar neuropathological featuresC H Adler, T G Beach, H A Shill, et al.
Journal of Internal Medicine|January 18, 2021
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesisJ L Liss, S Seleri Assunção, J Cummings, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Dementia and Geriatric Cognitive Disorders|September 14, 2007
Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's diseaseM N Sabbagh, T Lahti, D J Connor, et al.
Neurology|February 18, 2011
Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotesR J Caselli, A C Dueck, D E C Locke, et al.
Molecular Psychiatry|March 12, 2014
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter studyP M Doraiswamy, R A Sperling, K Johnson, et al.
European Journal of Neurology|August 24, 2017
GBA mutations in Parkinson disease: earlier death but similar neuropathological featuresC H Adler, T G Beach, H A Shill, et al.
Journal of Internal Medicine|January 18, 2021
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesisJ L Liss, S Seleri Assunção, J Cummings, et al.
Pageof 4